---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291317217.md"
description: "During Tuesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Creative Medical Tech (up 242.5%), Cuprina Holdings (up 70.62%), and Abivax (up 40.87%). Conversely, major losers featured Vistagen Therapeutics (down 70.2%), Universe Pharmaceuticals (down 52.39%), and Unicycive Therapeutics (down 40.91%). The report highlights these sharp price movements across various market capitalizations."
datetime: "2026-06-30T17:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291317217.md)
  - [en](https://longbridge.com/en/news/291317217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291317217.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **Creative Medical Tech** (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million.
-   **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) shares increased by 70.62% to $7.61. The market value of their outstanding shares is at $11.9 million.
-   **Abivax** (NASDAQ:ABVX) stock moved upwards by 40.87% to $135.45. The company's market cap stands at $7.6 billion.
-   **C4 Therapeutics** (NASDAQ:CCCC) stock moved upwards by 18.62% to $5.16. The company's market cap stands at $480.9 million.
-   **Bio Green Med Solution** (NASDAQ:BGMS) stock rose 17.59% to $0.85. The company's market cap stands at $3.9 million.
-   **ProMIS Neurosciences** (NASDAQ:PMN) shares moved upwards by 16.27% to $12.5. The market value of their outstanding shares is at $96.4 million.

### Losers

-   **Vistagen Therapeutics** (NASDAQ:VTGN) stock declined by 70.2% to $0.23 during Tuesday's regular session. The company's market cap stands at $31.1 million.
-   **Universe Pharmaceuticals** (NASDAQ:UPC) shares declined by 52.39% to $5.8. The company's market cap stands at $7.8 million.
-   **Unicycive Therapeutics** (NASDAQ:UNCY) stock declined by 40.91% to $4.55. The market value of their outstanding shares is at $210.9 million.
-   **Nuvectis Pharma** (NASDAQ:NVCT) stock decreased by 35.86% to $18.3. The company's market cap stands at $756.7 million.
-   **Tenon Medical** (NASDAQ:TNON) shares fell 27.31% to $0.32. The company's market cap stands at $5.2 million.
-   **Decoy Therapeutics** (NASDAQ:DCOY) shares declined by 26.05% to $7.09. The market value of their outstanding shares is at $5.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [VTGN.US](https://longbridge.com/en/quote/VTGN.US.md)
- [UNCY.US](https://longbridge.com/en/quote/UNCY.US.md)
- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [ABVX.US](https://longbridge.com/en/quote/ABVX.US.md)
- [CCCC.US](https://longbridge.com/en/quote/CCCC.US.md)
- [BGMS.US](https://longbridge.com/en/quote/BGMS.US.md)
- [NVCT.US](https://longbridge.com/en/quote/NVCT.US.md)
- [TNON.US](https://longbridge.com/en/quote/TNON.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [BGMSP.US](https://longbridge.com/en/quote/BGMSP.US.md)
- [TNONW.US](https://longbridge.com/en/quote/TNONW.US.md)

## Related News & Research

- [Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback](https://longbridge.com/en/news/296255704.md)
- [Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada](https://longbridge.com/en/news/296326332.md)
- [The Rare Earth Mirage: The Midstream Bet Hiding in Plain Sight (NASDAQ: EMAT)](https://longbridge.com/en/news/296940044.md)
- [FibroBiologics Regains Compliance with Nasdaq Trading Rules | FBLG Stock News](https://longbridge.com/en/news/297048305.md)
- [Greenland Mines (NASDAQ: GRML) Initial Assessment Values Sarfartoq at Up to $2.05B Pre-Tax NPV](https://longbridge.com/en/news/296932902.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**